The President of the European Commission, Ursula Der Line, announced that AstraZeneca has applied for the European Union to obtain a license for its vaccine against Corona.

And the European Union Medicines Regulatory Authority announced that it has received an application to register a third Corona virus vaccine in the European Union, AstraZeneca.

"The European Medicines Agency (EMA) has received an application for a conditional marketing authorization for the AstraZeneca COVID-19 vaccine," the Medicines Regulatory Authority said in a statement.

The statement stated that the evaluation of the vaccine by the agency will be done in a fast time frame, and a conclusion can be issued regarding the permission to use the drug in the European Union before January 29.

It is reported that the Pfizer / BioNTech vaccine was approved in the European Union on December 21. The European Commission issued the final approval for the vaccine on the same day, and after a few days, the drug began to be supplied to the countries of the Union.

This initial contract included the purchase of 300 million doses of the vaccine. Last Friday, the European Commission renewed its contract with Pfizer / BioNTech to purchase an additional 300 million doses of the Coronavirus vaccine, bringing the total to 600 million doses.

The Medicines Association also clarified that when using one bottle of the Pfizer / BioNTech vaccine, six doses are sufficient, not five doses, as was previously thought.

On January 6, the European Union approved the use of the second vaccine in the European Union, Moderna, and the contract with this company includes the purchase of up to 160 million doses of the COVID vaccine.

According to the European Commission, European Commission contracts will allow EU member states to receive a total of around 2.3 billion doses of coronavirus vaccines from different companies.

Source: Novosti

By:Nadeemy Haded